Cargando…

Mode of administration of dulaglutide: implications for treatment adherence

BACKGROUND: Medication complexity/burden can be associated with nonadherence in patients with type 2 diabetes mellitus (T2DM). Patients’ satisfaction with their treatment is an important consideration for physicians. Strategies like using longer acting efficacious agents with less frequent dosing ma...

Descripción completa

Detalles Bibliográficos
Autor principal:	Amblee, Ambika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898439/ https://www.ncbi.nlm.nih.gov/pubmed/27330280 http://dx.doi.org/10.2147/PPA.S82866

Ejemplares similares

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Advances in the treatment of type 2 diabetes: impact of dulaglutide
por: Thompson, Angela M, et al.
Publicado: (2016)

SUN-474 An Unusual Case of Poorly Differentiated Thyroid Carcinoma with an Excellent Prognosis
por: Pulipati, Vishnu Priya, et al.
Publicado: (2020)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
por: Edwards, Krystal L, et al.
Publicado: (2015)

Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide
por: Sawamura, Toshitaka, et al.
Publicado: (2022)

Clinical Characteristics Associated with Adherence and Persistence in Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide
por: Lee, David Seung U., et al.
Publicado: (2023)

SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma
por: Gorantla, Yamuna, et al.
Publicado: (2019)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
por: Torre, Enrico, et al.
Publicado: (2020)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level
por: Amblee, Ambika, et al.
Publicado: (2014)

Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2021)

Exacerbation of atrial fibrillation related to dulaglutide use
por: Lee, Jayden, et al.
Publicado: (2021)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

Case Report of Acute Pancreatitis Associated With Combination Treatment of Dulaglutide and Glipizide
por: Babajide, Oyedotun, et al.
Publicado: (2022)

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
por: Gurung, Tara, et al.
Publicado: (2015)

SAT-506 Rare Case of Durvalumab-Induced Thyroiditis, Transient Secondary Adrenal Insufficiency and Autoimmune Diabetes
por: Gorantla, Yamuna, et al.
Publicado: (2020)

Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study
por: Matsushita, Maya, et al.
Publicado: (2018)

Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study
por: Terui, Sakiko, et al.
Publicado: (2021)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption
por: Kyriakos, Georgios, et al.
Publicado: (2022)

Correction to Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2022)

SUN-938 Rare Case of Ectopic Cushing Syndrome Caused by ACTH Secreting Thymic Neuroendocrine Tumor in a Patient with Multiple Endocrine Neoplasia Type 1
por: Gorantla, Yamuna, et al.
Publicado: (2020)

Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
por: Robinson, Susan, et al.
Publicado: (2020)

Switching treatments in COPD: implications for costs and treatment adherence
por: Braido, Fulvio, et al.
Publicado: (2015)

Dulaglutide (Trulicity)-Induced Acute Pancreatitis: A Case Report
por: Khan, Abu baker, et al.
Publicado: (2023)

Medicines; Their Use and Mode of Administration
Publicado: (1865)

Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
por: Pulipati, Vishnu Priya, et al.
Publicado: (2021)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
por: Kugler, Anne J, et al.
Publicado: (2018)

OR30-06 Assessment of Dulaglutide Safety in Older Patient Populations in Rewind
por: Konig, Manige, et al.
Publicado: (2020)

A Rare Case of Dulaglutide-Associated Angioedema in a Male Patient
por: Karakousis, Nikolaos, et al.
Publicado: (2021)

The effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
por: Ruda, Alexandru Ioan, et al.
Publicado: (2023)

ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide
por: Bossi, Antonio C., et al.
Publicado: (2020)

Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide
por: Alatorre, Carlos, et al.
Publicado: (2017)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
por: MacIsaac, Richard J.
Publicado: (2020)

The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
por: Malkin, Samuel J. P., et al.
Publicado: (2022)

Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide
por: Ghosh, Aneesh
Publicado: (2021)

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
por: Quadri, Hamza, et al.
Publicado: (2021)

Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease
por: Kim, Sungmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2accav7o18cjum65vvjqlettk5